A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery

Active, not recruitingOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

August 11, 2023

Primary Completion Date

February 21, 2026

Study Completion Date

February 21, 2026

Conditions
Carcinoma, Non-Small-Cell Lung
Trial Locations (12)

100021

Cancer Hospital Chinese Academy of Medical Sciences., Beijing

101149

Beijing Chest Hospital, Beijing

150081

Harbin Medical University Cancer Hospital, Harbin

210029

Jiangsu Province Hospital (the First Affiliated Hospital With Nanjing Medical University), Nanjing

250117

Shandong Cancer Hospital, Jinan

430079

Hubei Cancer Hospital, Wuhan

450052

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

530021

Guangxi Cancer Hospital of Guangxi Medical University, Nanning

610041

Sichuan Provincial Cancer Hospital, Chengdu

710061

First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an

050000

The Fourth Hospital of Hebei Medical University, Shijiazhuang

030013

Shanxi Province Cancer Hospital, Taiyuan

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT05872763 - A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery | Biotech Hunter | Biotech Hunter